Welcome
10:30 a.m.-10:35 a.m.
Douglas Yee, Director, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
|
Session 1
Chairperson: Margaret Foti, Chief Executive Officer, American Association for Cancer Research, Philadelphia, PA
10:35 a.m.-12:20 p.m.
Welcome and Remarks
Margaret Foti
Cancer prevention and its vital role in the conquest of cancer
Margaret Foti
Presentation of the AACR Award for Lifetime Achievement in Cancer Prevention Research
Late-stage inhibition and other strategies for prevention of neoplasia
Lee W. Wattenberg, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
Extending the pioneering work of Lee Wattenberg on chemoprevention of lung carcinogenesis
Stephen S. Hecht, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
Personalized approach in lung cancer: Reverse migration strategy
Waun Ki Hong, University of Texas MD Anderson Cancer Center, Houston, TX
|
Session 2
Chairperson: Eva Szabo, National Cancer Institute, Bethesda, MD
1:05 p.m.-2:55 p.m.
Person-to-person differences in drug metabolism: Importance for cancer chemoprevention
Allan H. Conney, Rutgers, The State University of New Jersey, Piscataway, NJ
PPAR gamma activation as a strategy in aerodigestive cancer prevention: A surgeon's perspective
Frank G. Ondrey, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
A pathway approach to lung cancer chemoprevention in high-risk smokers
Stephen Lam, British Columbia Cancer Agency, Vancouver, BC, Canada
Rethinking the runway for successful development of chemoprevention for the clinic: Hard lessons learned
Frank L. Meyskens Jr., University of California Irvine Chao Family Comprehensive Cancer Center, Orange, CA
From mouse to man: The budesonide story and what it has taught us
Eva Szabo
|